An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Conditions

• Pulmonary Hypertension
• Interstitial Lung Disease

Interventions

• DRUG: Treprostinil Palmitil Inhalation Powder
• DRUG: Placebo

Sponsor

Insmed Incorporated